We are live on ! Find out more
HSA

Hussman Strategic Advisors Portfolio holdings

AUM $463M
1-Year Est. Return 16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+16%
3 Year Est. Return
+35.45%
5 Year Est. Return
+32.62%
10 Year Est. Return
+255.18%
AUM
$1.4B
AUM Growth
-$416M
Cap. Flow
-$548M
Cap. Flow %
-39.01%
Top 10 Hldgs %
15.67%
Holding
242
New
35
Increased
45
Reduced
67
Closed
45

Top Buys

Rank Stock Value
1
GSK icon
GSK
GSK
+$20.7M
2
CVX icon
Chevron
CVX
+$20.7M
3
STJ
St Jude Medical
STJ
+$20.3M
4
LH icon
Labcorp
LH
+$19.9M
5
MCD icon
McDonald's
MCD
+$19.2M

Top Sells

Rank Stock Value
1
AFL icon
Aflac
AFL
+$29.5M
2
CL icon
Colgate-Palmolive
CL
+$23.7M
3
GNRC icon
Generac Holdings
GNRC
+$23.2M
4
MUR icon
Murphy Oil
MUR
+$21.9M
5
MAT icon
Mattel
MAT
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 20.9%
2 Technology 18.98%
3 Consumer Discretionary 12.11%
4 Consumer Staples 9.66%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPB icon
151
Campbell Soup
CPB
$6.55B
$454K 0.03%
10,500
-492,000
-98% -$20.4M
CAJ
152
DELISTED
Canon, Inc.
CAJ
$448K 0.03%
14,000
+4,000
+40% +$128K
CSGS
153
DELISTED
CSG Systems International
CSGS
$441K 0.03%
+15,000
New +$415K
HHS icon
154
Harte-Hanks
HHS
$16.2M
$434K 0.03%
5,550
+3,000
+118% +$245K
MANT
155
DELISTED
Mantech International Corp
MANT
$419K 0.03%
14,000
+6,000
+75% +$171K
KLAC icon
156
KLA
KLAC
$239B
$406K 0.03%
63,000
+30,000
+91% +$189K
WLY icon
157
John Wiley & Sons Class A
WLY
$2.65B
$397K 0.03%
7,200
– –
POT
158
DELISTED
Potash Corp Of Saskatchewan
POT
$396K 0.03%
12,000
+2,000
+20% +$63.7K
WIT icon
159
Wipro
WIT
$19.6B
$387K 0.03%
163,829
-160,000
-49% -$344K
WX
160
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
$384K 0.03%
10,000
-10,000
-50% -$316K
LDOS icon
161
Leidos
LDOS
$14.5B
$349K 0.02%
+7,500
New +$346K
AFL icon
162
Aflac
AFL
$64.9B
$334K 0.02%
10,000
-900,000
-99% -$29.5M
PETS icon
163
PetMed Express
PETS
$41.7M
$333K 0.02%
20,000
+5,000
+33% +$78.1K
CCL icon
164
Carnival Corporation Ltd
CCL
$38.1B
$321K 0.02%
8,000
– –
SPLS
165
DELISTED
Staples Inc
SPLS
$310K 0.02%
19,500
+10,000
+105% +$156K
DRI icon
166
Darden Restaurants
DRI
$23.3B
$299K 0.02%
6,153
– –
KMI icon
167
Kinder Morgan
KMI
$71.7B
$270K 0.02%
+7,500
New +$263K
MCHP icon
168
Microchip Technology
MCHP
$40.3B
$268K 0.02%
12,000
-390,000
-97% -$8.18M
VIVO
169
DELISTED
Meridian Bioscience Inc
VIVO
$265K 0.02%
10,000
-2,500
-20% -$61.4K
ACO
170
DELISTED
AMCOL International Corp
ACO
$255K 0.02%
+7,500
New +$241K
RIG icon
171
Transocean
RIG
$5.89B
$247K 0.02%
+5,000
New +$245K
CWCO icon
172
Consolidated Water Co
CWCO
$467M
$240K 0.02%
17,000
-9,000
-35% -$127K
NHC icon
173
National Healthcare
NHC
$3.53B
$216K 0.02%
4,000
– –
GLW icon
174
Corning
GLW
$119B
$178K 0.01%
+10,000
New +$165K
KRO icon
175
KRONOS Worldwide
KRO
$693M
$143K 0.01%
+7,500
New +$118K
5 6
7
8 9

Similar funds

CPIM
Coalescence Partners Investment Management New York $463M AUM 8.27% 1-Year Est. Return
SHWM
Smith & Howard Wealth Management Atlanta, Georgia $462M AUM 12.39% 1-Year Est. Return
CWWM
Clear Wave Wealth Management Red Bank, New Jersey $463M AUM
NG
NatWest Group Edinburgh, Scotland, United Kingdom $462M AUM 47.31% 1-Year Est. Return
PC
ParaFi Capital New York $462M AUM 12.81% 1-Year Est. Return
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
PRCP
Pacific Ridge Capital Partners Lake Oswego, Oregon $462M AUM 40.76% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Hussman Strategic Advisors's Q4 2013 Portfolio in Review

As of Q4 2013, Hussman Strategic Advisors held 242 positions worth $1.4B, down 23% from $1.82B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Hussman Strategic Advisors withdrew a net $548M in Q4 2013, closing 45 positions and reducing 67 holdings. Its most notable exit was Colgate-Palmolive, an estimated $23.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Hussman Strategic Advisors opened a new position in St Jude Medical worth $21.7M.

  • Hussman Strategic Advisors's largest Q4 2013 buy was St Jude Medical: 350,000 shares worth $21.7M.
  • Hussman Strategic Advisors added most to GSK in Q4 2013, an estimated $20.7M increase.
  • Hussman Strategic Advisors's biggest Q4 2013 reduction was Aflac, cutting an estimated $29.5M.
  • Hussman Strategic Advisors fully exited Colgate-Palmolive in Q4 2013, selling an estimated $23.7M.
  • Hussman Strategic Advisors's ten largest holdings make up 16% of its $1.4B portfolio in Q4 2013.
  • Hussman Strategic Advisors opened 35 new positions and closed 45 in Q4 2013.
  • Hussman Strategic Advisors's portfolio value fell 23% quarter-over-quarter to $1.4B.

Based on Hussman Strategic Advisors's 13F filing for Q4 2013, filed 11 Feb 2014.